Check your eligibility now & get in touch with a study center

CHECK ELIGIBILITY

Are you a patient with moderate to severe plaque psoriasis?

Have you treated your condition with adalimumab (Humira®) and did it become less effective on your plaque psoriasis within the last 6 months? If so, you may be eligible for a clinical research study with etanercept (Enbrel®) which is also approved for moderate to severe plaque psoriasis. Qualified participants will receive an initial consultation, study-related examinations, and study medication.
Plaque psoriasis image

Video title

Diabetes study trial

Join our Diabetes Study Trial and contribute to empowering medical research. We are exploring groundbreaking techniques to manage and potentially cure diabetes. Your participation could help millions navigate this medical condition better and enjoy a healthier life

Person image
Roberta Hills, PhD
Professor at the University of Washington
TrialX is developing novel, proprietary technologies that enable patients to find and learn about clinical trials that match their health conditions and connect with the trial investigators effortlessly using a unique web messaging platform.
Person image
Roberta Hills, PhD
Professor at the University of Washington
TrialX is developing novel, proprietary technologies that enable patients to find and learn about clinical trials that match their health conditions and connect with the trial investigators effortlessly using a unique web messaging platform.
Email
Download
Print